Climb Bio Inc.

NASDAQ: CLYM · Real-Time Price · USD
1.93
0.21 (12.21%)
At close: Aug 15, 2025, 3:59 PM
1.92
-0.55%
After-hours: Aug 15, 2025, 07:44 PM EDT

Climb Bio Income Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a
Operating Income
-82.02M -40.27M -45.13M -35.67M
Interest Income
8.13M 4.62M 1.38M n/a
Pretax Income
-73.9M -35.12M -45.24M -47.48M
Net Income
-73.9M -35.12M -45.24M -47.48M
Selling & General & Admin
16.02M 24.86M 18.92M 12.35M
Research & Development
14.34M 15.41M 26.21M 23.32M
Other Expenses
51.66M n/a n/a n/a
Operating Expenses
82.02M 40.27M 45.13M 35.67M
Interest Expense
n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
82.02M 40.27M 45.13M 35.67M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
48.16M 26.99M 26.31M 12.26M
Shares Outstanding (Diluted)
48.16M 26.99M 26.31M 12.26M
EPS (Basic)
-1.53 -1.3 -1.72 -4.24
EPS (Diluted)
-1.53 -1.3 -1.72 -4.24
EBITDA
-30.36M -40.27M -45.13M -35.67M
EBIT
-30.36M -40.27M -45.13M -35.67M
Depreciation & Amortization
n/a n/a n/a n/a